Theoretical Risks: Since BPC157 promotes angiogenesis, there are speculative concerns that it could support abnormal tissue growth under certain conditions
Its potential to accelerate tissue regeneration has made it a promising candidate for addressing joint pain, mobility issues, and injury recovery
As research compounds, they are typically available in a lyophilized powdered form, requiring reconstitution before use
It is not FDA-approved, and this page covers research evidence rather than human-use guidance
Subcutaneous injection provides systemic bioavailability for joint, tendon, muscle, and broader tissue repair indications, complementing the gut-specific action of oral BPC-157